4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-056353
Chief Technology Officer sold 20,000 shares at $6.03 ($120,600)
- Chief Technology Officer gave up 3,203 shares (to pay taxes)
- Chief Technology Officer acquired 9,344 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Yan Ming Chief Technology Officer | 2023-11-18 | Option exercise | +1,981 | 7,777,943 | D | ||
| Yan Ming Chief Technology Officer | 2023-11-18 | Shares withheld for taxes | −772 | $5.98 | $4,617 | 7,777,171 | D |
| Yan Ming Chief Technology Officer | 2023-11-18 | Option exercise | +7,363 | 7,784,534 | D | ||
| Yan Ming Chief Technology Officer | 2023-11-18 | Shares withheld for taxes | −2,431 | $5.98 | $14,537 | 7,782,103 | D |
| Yan Ming Chief Technology Officer | 2023-11-20 | Sale | −20,000 | $6.03 | $120,600 | 7,762,103 | D |
| Derivatives | |||||||
| Yan Ming Chief Technology Officer | 2023-11-18 | Option exercise · Restricted Stock Units | −1,981 | 17,180 | D | ||
| Yan Ming Chief Technology Officer | 2023-11-18 | Option exercise · Restricted Stock Units | −7,363 | 98,179 | D | ||
| Open-market sales · 20,000 sh · avg $6.03 · $120,600 | |||||||
Loading xslF345X05/doc4.xml…